Part of the blood–ocular barrier that prevents certain substances from entering the retina
The blood–retinal barrier , or the BRB , is part of the blood–ocular barrier that consists of cells that are joined tightly together to prevent certain substances from entering the tissue of the retina.[ 1] It consists of non-fenestrated capillaries of the retinal circulation and tight-junctions between retinal epithelial cells preventing passage of large molecules from choriocapillaris into the retina .
Structure
The blood retinal barrier has two components: the retinal vascular endothelium and the retinal pigment epithelium .[ 2] Retinal blood vessels that are similar to cerebral blood vessels maintain the inner blood-ocular barrier. This physiological barrier comprises a single layer of non-fenestrated endothelial cells , which have tight junctions . These junctions are impervious to tracer , so many substances can affect the metabolism of the eyeball . The retinal pigment epithelium maintains the outer blood–retinal barrier.[ 3]
Clinical significance
Diabetic retinopathy
Diabetic retinopathy , eye damage that frequently occurs as a result of diabetes , is related to the breakdown of the blood–retinal barrier.[ 4] The barrier becomes more leaky in patients with diabetic retinopathy.[ 5]
Other animals
Animal models have shown that the blood–retinal barrier becomes more permeable to substances in hypertensive animals (those with high blood pressure ).[ 6]
See also
References
^ Biologyonline.org. Blood–retinal barrier [permanent dead link ] . Retrieved on July 19, 2007.
^ Vinores, SA (1995). "Assessment of blood–retinal barrier integrity". Histology and Histopathology . 10 (1): 141– 54. PMID 7756735 .
^ Pardianto, G; et al. (2005). "Blood–retinal-barrier". Mimbar Ilmiah Oftalmologi Indonesia . 2 : 68– 69.
^ Azza B. El-Remessy, Mohamed Al-Shabrawey, Yousuf Khalifa, Nai-Tse Tsai, Ruth B. Caldwell and Gregory I. Liou. 2006. Neuroprotective and Blood–retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes. American Journal of Pathology , Volume 168, Pages 235-244. Retrieved on July 19, 2007.
^ Lobo, CL; Bernardes, RC; Cunha-Vaz, JG. (2000). "Alterations of the Blood–retinal Barrier and Retinal Thickness in Preclinical Retinopathy in Subjects With Type 2 Diabetes" . Archives of Ophthalmology . 118 (10): 1364– 1369. doi :10.1001/archopht.118.10.1364 . hdl :10400.4/836 . PMID 11030818 .
^ S Lightman, E Rechthand, C Latker, A Palestine and S Rapoport. Assessment of the permeability of the blood–retinal barrier in hypertensive rats. Hypertension , Volume 10, Pages 390-395. Retrieved on July 19, 2007.